Skip to main content
Year archive

Medivir — 2019 filings

All 19 regulatory filings released by Medivir (MVIR) in 2019, sourced directly from the official regulator.

19 Filings
2019 Period
2019 filings (19)
Filing Released Lang
Futilitetsanalys genomförd av fas II kombinationsstudien med birinapant och Keytruda® i patienter med tjocktarmscancer
Regulatory Filings
2019-12-16 Swedish
Futility analysis performed of the phase II combination study with birinapant and Keytruda® in colorectal cancer patients
Regulatory Filings
2019-12-16 English
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-11-27 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report 9M 2019
2019-11-27 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2019-08-28 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H2 2019
2019-08-28 English
Selective effect signal on liver cancer tissue in phase Ia study with MIV-818
Earnings Release FY 2019
2019-06-13 English
Selektiv effektsignal i levercancervävnad i fas Ia-studien med MIV-818
Regulatory Filings
2019-06-13 Swedish
Beslut vid årsstämma i Medivir den 9 maj 2019
AGM Information
2019-05-09 Swedish
Resolutions at the Annual General Meeting in Medivir on 9 May 2019
AGM Information
2019-05-09 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-03 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-03 English
Notice of Annual General Meeting of Medivir AB (publ)
AGM Information
2019-04-10 English
Kallelse till årsstämma i Medivir AB (publ)
AGM Information
2019-04-10 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-08 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-08 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-20 English
Interim / Quarterly Report 2018
Interim / Quarterly Report FY 2018
2019-02-14 Swedish
Audit Report / Information 2018
Audit Report / Information FY 2018
2019-02-14 English